MetaCap

Compass Therapeutics Balance Sheet

NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.6882+0.0097 (+1.43%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Compass Therapeutics financial position

At the end of fiscal 2025, Compass Therapeutics reported total assets of $219.6 million, up 56.4% from a year earlier against total liabilities of $22.8 million. Shareholders' equity stood at $196.8 million, or 89.6% of assets. The company held $30.6 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 15.02, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

Compass Therapeutics balance sheet (annual)

Compass Therapeutics annual balance sheet
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20202020-03-31FY 20192019-12-31FY 20192019-03-31
Cash & Equivalents30.64M43.48M24.23M34.95M144.51M47.08M3.75K25.30M4.87K
Short-Term Investments178.26M83.24M128.23M151.66M0————
Total Current Assets209.82M132.75M153.88M194.79M147.10M50.20M3.75K26.24M4.87K
Property, Plant & Equipment102.00K353.00K898.00K1.57M2.24M1.13M—3.75M—
Total Assets219.59M140.40M156.88M199.65M153.76M51.91M3.75K30.38M4.87K
Accounts Payable1.58M2.25M4.09M3.38M867.00K1.06M8.71K629.00K3.33K
Short-Term Debt————07.47M—5.58M—
Total Current Liabilities13.97M8.87M7.80M16.17M10.63M10.10M111.82K9.82M75.45K
Long-Term Debt————01.87M—9.29M—
Total Liabilities22.80M15.17M8.34M18.01M13.68M11.97M111.82K19.11M75.45K
Shareholders' Equity196.79M125.23M148.54M181.64M140.08M39.95M-124.76M11.27M-95.29M
Retained Earnings-431.17M-364.68M-315.31M-272.81M-233.59M-151.41M-108.57K-121.91M-71.09K
Total Debt————09.33M—14.87M—
Net Cash (Debt)208.91M126.72M152.46M186.61M144.51M37.74M3.75K10.43M4.87K
Shares Outstanding178.32M137.82M127.67M126.30M100.83M51.22M5.00M7.03M5.00M

This table shows 9 annual periods of Compass Therapeutics's balance sheet, from FY 2025 back to FY 2019, across 15 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow CMPX's reporting calendar. What is a balance sheet?

More financial data